35 day month

Lundbeck to Present Broad Range of Data on Migraine and Brain Health at 75th Annual Meeting of the American Academy of Neurology

Retrieved on: 
Monday, April 17, 2023

Lundbeck today announced new neuroscience data will be presented at the 75th Annual Meeting of the American Academy of Neurology taking place in Boston and virtually from April 22-27, 2023.

Key Points: 
  • Lundbeck today announced new neuroscience data will be presented at the 75th Annual Meeting of the American Academy of Neurology taking place in Boston and virtually from April 22-27, 2023.
  • Proactive care for high-frequency, worsening disease,” focusing on studies and techniques for individualizing preventive care to improve collaboration and outcomes.
  • “At Lundbeck, researching and developing transformative medicines for brain health is at the core of what we do.
  • Additional data to be presented by Lundbeck at AAN 2023 is listed below.

Verustat Announces Clinical Study Results for RPM

Retrieved on: 
Monday, January 9, 2023

Verustat , a full-service remote care management company, today announced promising clinical results showing the ability of Verustat’s Remote Patient Monitoring (RPM) to lower blood pressure.

Key Points: 
  • Verustat , a full-service remote care management company, today announced promising clinical results showing the ability of Verustat’s Remote Patient Monitoring (RPM) to lower blood pressure.
  • New research published online in Telemedicine and e-Health shows a significant reduction in mean arterial pressure (MAP) for hypertensive patients using the Verustat RPM program.
  • Additional findings in a separate, unpublished study: In the first 3 months on the program, Verustat RPM patients with a Charlson comorbidity index >2 were compared to a matched control group who were not using RPM.
  • The patients on the Verustat RPM program showed:
    - A 29% reduction in ER visits and a 16% reduction in hospitalizations.